Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term thyroid and parathyroid outcomes after DBR thyroid protection during 131I-MIBG treatment in childhood neuroblastoma survivors
NL-OMON37078Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of Potassium iodide, methimazole and levothyroxine sodium in Not applicable and thyroid disease, sponsored by Amsterdam University Medical Center. Primary endpoints: Thyroid dysfunction and Thyroid nodules or carcinoma. Started Mar 2013; status: active, not recruiting.
02
Drugs
Potassium iodidemethimazolelevothyroxine sodium
03
Conditions
Not applicablethyroid disease
Beyond the preview
Go deeper on NL-OMON37078.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37078.